Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001724310-26-000004

President and CEO sold 35,198 shares at $16.50 ($580,767)

From the SEC's structured data for this filing

Trades in this filing

Watts Ryan J. · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-01-06 Sale : show line 1 in the form −35,198 $16.50 $580,767 296,833 D
Open-market sales · 35,198 sh · avg $16.50 · $580,767
Loading xslF345X05/wk-form4_1767907202.xml…